Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer
Treatment for advanced gastric cancer is challenging. Epidermal growth factor receptor (EGFR) contributes to the proliferation and development of gastric cancer (GC), and its overexpression is associated with unfavorable prognosis in GC. Cetuximab, a monoclonal antibody targeting EGFR, failed to imp...
Main Authors: | Huanrong Ma PhD, Jingjing Wu Bachelor, Minyu Zhou PhD, Jianhua Wu PhD, Zhenzhen Wu PhD, Li Lin PhD, Na Huang PhD, Wangjun Liao PhD, Li Sun PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354211045349 |
Similar Items
-
Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial
by: Yanqing Zheng PhD, et al.
Published: (2021-05-01) -
lncRNA ROR Promotes Gastric Cancer Drug Resistance
by: Shuai Wang PhD, et al.
Published: (2020-01-01) -
Gastric lipoma of the pylorus – case report of an incidental finding
by: Aleksandar Georgiev, PhD, et al.
Published: (2021-07-01) -
Determination of P53 gene mutations in gastric cancer by PCR-SSCP
by: HR.Joshaghani (Ph.D), et al.
Published: (2003-09-01) -
Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636
by: Jianxiang Song PhD, et al.
Published: (2020-10-01)